Latest Health News

Immuron Limited has inked an exclusive US distribution deal for PROIBS®, a European-certified medical device targeting abdominal discomfort, marking a key step in its digestive health portfolio growth.

Brightstar Resources has secured over A$380 million in funding to fully finance its Goldfields Project, commencing construction of a 1.5Mtpa Laverton processing plant with first gold targeted mid-2027, while expanding its Sandstone resource base to 2.9Moz.

Thrive Tribe Technologies (ASX:1TT) has secured $500,000 through a placement of 500 million shares at $0.001 each, aiming to support general working capital and cover placement costs.

WasteCo Group has initiated a $2 million share placement at $0.007 per share to fund its ambitious turnaround and growth strategy amid a FY 2026 loss. A Share Purchase Plan will follow, offering existing investors a chance to participate on the same terms.

AdAlta’s partner SHcell has gained regulatory approval to provide the BZDS1901 CAR-T therapy to advanced mesothelioma patients in China’s Hainan Boao Lecheng special access zone, marking a key milestone in real-world data collection and treatment availability.

Kantra Copper (ASX:KAN) showcased a robust growth strategy at the Copper to the World Conference, spotlighting its Kanmantoo mine extension, Emily Star development, and advancing exploration projects. The company maintains strong production guidance and financial health amid a tightening copper market.

Minbos Resources edges closer to operational readiness at Cabinda with a US$1.3 million initial drawdown from Banco de Fomento Angola and steel framework shipment underway for Phase 2 construction.

Australian Unity Limited (ASX:AYU) posted a statutory loss of $155.2 million for FY2026, reflecting regulatory headwinds, transformation costs, and sector disruptions, while advancing its climate risk management and strategic portfolio adjustments.

Percheron Therapeutics has raised $2.3 million through an institutional placement to fully fund its upcoming acute myeloid leukemia clinical trial led by Vanderbilt Health.

Ramsay Health Care has finalised its $251 million purchase of National Capital Private Hospital in Canberra, expanding its footprint in key therapeutic areas and expecting earnings accretion within a year.

Artrya has launched its AI-powered Salix® platform commercially in the US, securing three foundation health systems and raising $80 million to fuel growth. With FDA clearance for its Coronary Plaque module and a pivotal clinical study underway, the company is poised for scaling revenues amid a strong balance sheet.

Optiscan Imaging has launched a 35-patient clinical trial in the US to test its InVue™ and InForm™ platforms in head and neck cancer surgery, aiming to bolster its FDA submissions later this year.